The largest database of trusted experimental protocols

Ivis imaging system 200 series

Manufactured by PerkinElmer
Sourced in United States

The IVIS Imaging System 200 Series is a preclinical in vivo imaging platform designed for bioluminescent and fluorescent imaging applications. The system utilizes a highly sensitive charge-coupled device (CCD) camera to capture real-time images of small animal models.

Automatically generated - may contain errors

11 protocols using ivis imaging system 200 series

1

In Vivo Bioluminescence Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anaesthetized with isofluorane and injected intraperitoneally with 10 μl per g of body weight d-luciferin (15 mg/ml; Perkin-Elmer). Bioluminescence images, each typically 3 min, large binning, f/stop 1, were then taken 10–20 min post-luciferin injection, using an IVIS 200 series imaging system (Perkin-Elmer).
+ Open protocol
+ Expand
2

In Vivo Bioluminescence Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anaesthetized with isofluorane and injected i.p. with 10 µl/g d-luciferin (15 mg/ml; Perkin-Elmer). Sequential bioluminescence images, each typically 3 min, large binning, f/stop 1, were then taken 10–20 min post-luciferin injection, using an IVIS 200 series imaging system (Perkin-Elmer). Light output was quantified at peak signal intensity, typically 14 or 18 min post-luciferin injection, using Living Image software (Perkin-Elmer).
+ Open protocol
+ Expand
3

Astrocyte Activation Dynamics in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Astrocyte activation in 10-week-old male Gfap-luc mice was quantified before (baseline) and at 2 h, 6 h, 24 h, 48 h, 72 h, and 96 h after i.p. administration of either 0, 63, or 250 μg/kg TNF-α (n = 7 per group). Brain bioluminescence was detected as described previously [27 (link), 35 (link)]. Briefly, Gfap-luc mice were anesthetized by inhalation of 2% isoflurane in 1 L/min oxygen, shaved on the head, and injected with 126 mg/kg D-luciferin (Promega, product ID E1601) in the tail vein. Three minutes later the animals were scanned with a charge-coupled device camera (IVIS Imaging System 200 Series, PerkinElmer) mounted on a dark box. Photon emission from the whole brain was measured using Living Image 3.2 software (PerkinElmer) in a region of interest (ROI) that was kept constant across mice. Bioluminescence coming from the ears was considered to be basal Gfap activity and was excluded from the ROI. Imaging signals were measured in physical units of surface radiance (photons/s/cm2/steradian [sr]).
+ Open protocol
+ Expand
4

In Vitro and In Vivo Bioluminescence Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
BLI of cells and animals was performed with an IVIS Imaging System 200 Series (PerkinElmer) and quantitated with Living Image® software by measuring photon flux (photons/s/cm2/steradian) in regions of interest drawn around appropriate signals. For in vitro BLI, cells were treated with cell lysis buffer (Promega) and placed in 96-well black imaging plates, and 100 μL D-Luciferin reagent (1.5 mg/mL) (Gold Biotechnology) were added to each well and mixed well, and 30 sec later BLI was performed and the signal was acquired for 1 min. For in vivo BLI, anesthetized mice were injected intraperitoneally with 75 mg/kg of D-Luciferin and images were acquired 2–5 min after injection. Acquisition times were 2 min initially and were reduced in accordance with signal intensity to avoid saturation.
+ Open protocol
+ Expand
5

In Vivo Bioluminescence Imaging of Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
BLI of animals was performed with an IVIS Imaging System 200 Series (PerkinElmer, Waltham, MA, USA) and quantitated with Living Image® software by measuring photon flux (photons/s/cm2/steradian) in regions of interest drawn around appropriate signals. For in vivo BLI, anesthetized mice (n = 5) were injected intraperitoneally with 75 mg/kg of D-Luciferin, and images were acquired 2 to 5 min after injection. Acquisition times were 2 min initially, and were reduced in accordance with signal intensity to avoid saturation.
+ Open protocol
+ Expand
6

Visualizing GFP-Expressing Cells in Bioreactor

Check if the same lab product or an alternative is used in the 5 most similar protocols
For direct imaging of the GFP-mMSCs attached to the 160 cm2 column at the end of culture, the column was removed and fluorescence microscopy (Nikon Eclipse Ti-u with a Nikon Digital Sight Ds-Qimc camera, Japan) was used to image GFP expressing cells.
To image the whole bioreactor using the IVIS Imaging System 200 series (Caliper, PerkinElmer, MA, USA), the cells were fixed with 4% paraformaldehyde and were stained with 10 μg/mL propidium iodide (PI, Invitrogen) for 10 minutes. The bioreactor was then washed with PBS and stored on ice prior to imaging. As negative controls, bioreactors containing no cells underwent the same fixing and staining process. The bioreactors were imaged with an excitation filter of 520 nm and an emission filter of 620 nm. The thresholds were adjusted to remove background auto florescence.
+ Open protocol
+ Expand
7

Bioluminescence Imaging of Cells and Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
BLI of cells and animals was performed with an IVIS Imaging System 200 Series (PerkinElmer) and quantitated with Living Image® software by measuring photon flux (photons/s/cm2/steradian) in regions of interest drawn around appropriate signals. For in vitro BLI, 105 H441, CB-MSC or fusion progeny cells were resuspended in 50 μL PBS and placed in 96-well black imaging plates, and 50 μL D-Luciferin reagent (1.5 mg/mL) (Gold Biotechnology) were added to each well and mixed well, and 30 sec later BLI was performed and the signal was acquired for 1 min. For in vivo BLI, anesthetized mice were injected intraperitoneally with 75 mg/kg of D-Luciferin and images were acquired 2–5 min after injection. Acquisition times were 2 min initially and were reduced in accordance with signal intensity to avoid saturation.
+ Open protocol
+ Expand
8

Longitudinal Bioluminescence Imaging of Tumor Burden

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were imaged from first week to eighth week post-inoculation to assess tumor burden. Mice were anesthetized using isoflurane and imaged after 10 min of D-luciferin (1.5 mg/mouse, Perkin Elmer, Waltham, MA, USA) I.P. injection using an IVIS Imaging System 200 Series (Perkin Elmer, Waltham, MA, USA). All the images were acquired by auto exposure. Using Living Image 4.7.4 software, region of interest (ROI) was generated to cover whole body, and the total flux (p/s) was obtained.
+ Open protocol
+ Expand
9

In Vivo Bioluminescence Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the mice were weekly imaged from 1st~8/9th week of post-inoculation to access the tumor burden. For this, mice were anesthetized using 3% isoflurane and given D-luciferin (1.5 mg/mouse, Perkin Elmer, Waltham, MA, USA) via intraperitoneal injection. Mice were imaged in an IVIS Imaging System 200 Series (Perkin Elmer, Waltham, MA, USA). Images were obtained by auto exposure, and to acquire the total flux (p/s), a region of interest was created to cover the whole body using Living Image 4.7.4 software.
+ Open protocol
+ Expand
10

Monitoring Transdermal Cy5.5 Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anesthetized mice
received microneedle patches containing encapsulated
Cy5.5 on the right upper site of dorsal skin for different amounts
of time. The Cy5.5 fluorescence signal was monitored using the IVIS
Imaging System 200 Series (PerkinElmer Inc.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!